179 related articles for article (PubMed ID: 28255354)
41. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
[TBL] [Abstract][Full Text] [Related]
42. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.
Park J; Sun B; Yeo Y
J Control Release; 2017 Oct; 263():90-101. PubMed ID: 28049022
[TBL] [Abstract][Full Text] [Related]
43. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
45. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
[TBL] [Abstract][Full Text] [Related]
46. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
47. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
48. l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells.
Niu S; Bremner DH; Wu J; Wu J; Wang H; Li H; Qian Q; Zheng H; Zhu L
Drug Deliv; 2018 Nov; 25(1):1275-1288. PubMed ID: 29847177
[TBL] [Abstract][Full Text] [Related]
49. Radionuclide Imaging-Guided Chemo-Radioisotope Synergistic Therapy Using a
Li Z; Wang B; Zhang Z; Wang B; Xu Q; Mao W; Tian J; Yang K; Wang F
Mol Ther; 2018 May; 26(5):1385-1393. PubMed ID: 29567310
[TBL] [Abstract][Full Text] [Related]
50. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
51. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
52. Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment.
Zhang Z; Zhang J; Jiang M; Zhao L; Li S; Sun H; Yang F; Liang H
Mol Pharm; 2020 Apr; 17(4):1405-1414. PubMed ID: 32096645
[TBL] [Abstract][Full Text] [Related]
53. Nanoparticle-mediated internal radioisotope therapy to locally increase the tumor vasculature permeability for synergistically improved cancer therapies.
Liang C; Chao Y; Yi X; Xu J; Feng L; Zhao Q; Yang K; Liu Z
Biomaterials; 2019 Mar; 197():368-379. PubMed ID: 30703742
[TBL] [Abstract][Full Text] [Related]
54. Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.
Wu J; Wang Q; Dong X; Xu M; Yang J; Yi X; Chen B; Dong X; Wang Y; Lou X; Xia F; Wang S; Dai J
Theranostics; 2021; 11(8):3710-3724. PubMed ID: 33664857
[TBL] [Abstract][Full Text] [Related]
55. Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy.
Tian L; Chen Q; Yi X; Chen J; Liang C; Chao Y; Yang K; Liu Z
Small; 2017 Jul; 13(25):. PubMed ID: 28544324
[TBL] [Abstract][Full Text] [Related]
56. Palmitic acid-modified human serum albumin paclitaxel nanoparticles targeting tumor and macrophages against breast cancer.
Xiang L; Fang C; Feng J; Tan Y; Wu Q; Zhou X; Li J; Gong T
Eur J Pharm Biopharm; 2023 Feb; 183():132-141. PubMed ID: 36592736
[TBL] [Abstract][Full Text] [Related]
57. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
[TBL] [Abstract][Full Text] [Related]
58. Redox-responsive paclitaxel-pentadecanoic acid conjugate encapsulated human serum albumin nanoparticles for cancer therapy.
Zhang Y; Wang J; Xing H; Liu C; Li X
Int J Pharm; 2023 Mar; 635():122761. PubMed ID: 36822341
[TBL] [Abstract][Full Text] [Related]
59. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
60. Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment To Improve Chemoradiation Therapy.
Meng L; Cheng Y; Gan S; Zhang Z; Tong X; Xu L; Jiang X; Zhu Y; Wu J; Yuan A; Hu Y
Mol Pharm; 2018 Feb; 15(2):447-457. PubMed ID: 29261319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
